Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

about

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

Item

http://www.wikidata.org/entity/Q54953677

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

@en

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

@nl

type

Item

label

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

@en

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

@nl

prefLabel

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

@en

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

@nl

P1476

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

@en

P2093

Brigitte Rack

http://www.w3.org/2001/XMLSchema#string

Erich-Franz Solomayer

http://www.w3.org/2001/XMLSchema#string

Isabell Witzel

http://www.w3.org/2001/XMLSchema#string

Karin Milde-Langosch

http://www.w3.org/2001/XMLSchema#string

Klaus Pantel

http://www.w3.org/2001/XMLSchema#string

Malgorzata Banys-Paluchowski

http://www.w3.org/2001/XMLSchema#string

Sabine Kasimir-Bauer

http://www.w3.org/2001/XMLSchema#string

Sabine Riethdorf

http://www.w3.org/2001/XMLSchema#string

Tanja Fehm

http://www.w3.org/2001/XMLSchema#string

Volkmar Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Mutant c-Ki-ras p21 protein in chemical carcinogenesis in humans exposed to vinyl chloride.

Oncogene proteins as biomarkers in the molecular epidemiology of occupational carcinogenesis. The example of the ras oncogene-encoded p21 protein.

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

A landscape of driver mutations in melanoma

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Comprehensive molecular characterization of human colon and rectal cancer

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

Targeting RAS signalling pathways in cancer therapy

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

P2888

s12885-018-4282-0

P304

541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4282-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter A. Fasching

Bahriye Aktas

P577

2018-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103876102

http://www.w3.org/2001/XMLSchema#string

P698

29739347

http://www.w3.org/2001/XMLSchema#string

P932

5941516

http://www.w3.org/2001/XMLSchema#string